Recruiting PRE-I-SPY Phase I/Ib Oncology Platform Program NCT05868226 Conditions Breast Diseases, Breast Neoplasms, ER Positive Breast Cancer, +29 more Locations The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center — Birmingham, Alabama, United States Moffitt Cancer Center — Tampa, Florida, United States The University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois, United States UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital — New Lenox, Illinois, United States View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd NCT07683754 Conditions Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more Locations Not specified View Trial Details
Not Yet Recruiting Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib NCT07428018 Conditions Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more Locations Istituto di Ricerche Farmacologiche Mario Negri IRCCS — Milan, MI, Italy View Trial Details
